Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LEARN FAST, WATCH the amazing LXGTF video: https://vimeo.com/183611304
WHAT IS LXGTF in SHORT! "Breakthrough technology" is a real understatement. In LXGTF HeartSentry you have a simple, affordable, portable device that requires no expert training to use and yet by measuring endothelial function it can knock the wind out of the diseases that cause 25% of ALL deaths in the modern world (heart disease and stroke)Its only competition area devices that cost up to six figures, can fill a small room and require medical training to operate.
Think about taking some more shares here today! Good opportunity!
Good morning everybody!
STEP BEFORE OTHERS! Endothelial function measurement predicts when arteries are vulnerable to developing atherosclerosis
WHY LXGTF is better? Knowing the core health of the cardiovascular system is critical to preventing future heart attacks and strokes
• Monitoring cardiovascular health changes over time is key to prevention via lifestyle modification, physician care and ongoing monitoring.
• Traditional measures of blood pressure and cholesterol measurements are only partial indicators of cardiovascular health.
exactly different market completely
Super smart LXGTF Management Team: https://lexingtonbiosciences.com/company/management/
Good explanation of the matter... Article by Jonathan Maltz, "What is Endothelial Function..." : https://lexingtonbiosciences.com/news/endothelial-function-important-health/
Study for tomorrow...LXGTF Corporate Profile: https://lexingtonbiosciences.com/investors/corporate-profile/
something to consider yep
GOOD ARTICLE RECENTLY RELEASED
https://insiderfinancial.com/lexington-bioscien-otcmktslxgtf-venturing-into-fortune-500-territory
Lexington’s President Eric Willis comments, “After nine months of concerted effort by our design and production team, the arrival of our first human-use HeartSentry devices allows us to accelerate our plans to move ahead with our pilot study. Diablo Clinical Research is a proven and respected establishment with the capability to launch our research program efficiently and cost-effectively. They have been extremely helpful in the determination process which has led to today’s announcement. We are excited to begin this next step of our development phase, and look forward to sharing quantifiable results in the near future.
http://techstockinsider.com/lexington-biosciences-lxgtf-lnb-engages-clinical-research-organization/?utm_medium=Social&utm_source=TSI_Social_Link&utm_campaign=TSI_Social_1130
slow start of the week, just testing patience but great stock
looks like opportunity time
SUMMARY LXGTF : Lexington BioSciences (CSE: LNB) (OTCQB: LXGTF) is developing
the HeartSentry, a new non-invasive diagnostic tool for accurately measuring and monitoring cardiovascular health.
• The HeartSentry measures the function of the endothelium – the critical inner lining of a person’s cardiovascular system.
• The core research and IP portfolio has been exclusively licensed to the
company.
• Lexington is in final stages of releasing the product into clinical studies for FDA
approval.
• The cardiovascular diagnostic market is growing fast and evolving into
personalized medicine.
• The goal is to make HeartSentry the standard of care for cardiologists, general practitioners, and ultimately patients first line evaluation of cardiovascular health.
• We seek the participation of dedicated stakeholders and committed
partners who share our vision of the future of cardiovascular personalized
medicine.
that's true SuperPac, hold on and see :)
yes pretty slow
COOL! The corporation has also approved the hiring of an independent third party to determine a valuation for each of the technologies developed and acquired. We will be expecting a third party to provide management a numerical valuation determination, publish a white paper and provide management with relative research for commercial development into several mature and emerging industries.
Hi everybody, what's up?
GOOD STRATEGY. Our team of designers and developers have really caught he vision of what we are trying to build and what we will accomplish in blending and marrying the cryptocurrency and online retail sectors. We plan to give people an entirely unique online retail experience and offer them flexibility and freedom in how they choose to pay for their purchases. Our partnership with BitTraderLive is a huge leap forward in allowing us to accomplish and achieve the vision we have outlined for this exciting new opportunity
LOVE IT! The Cryx marketplace will feature mid to high end consumer products that can all be bought and sold utilizing the Cryx token. Mr. Sills continued, "We are envisioning a product where a customer can log into their app, trade and exchange tokens, shop for their favorite products, move tokens between wallets and transfer money to their connected card, bank or other online wallet accounts. Our team of designers and developers have really caught the vision of what we are trying to build and what we will accomplish in blending and marrying the cryptocurrency and online retail sectors. We will be providing customers an entirely unique online retail experience and offer them flexibility and freedom in how they choose to pay for their purchases. Our partnership with BitTraderLive is a huge leap forward in allowing us to accomplish and achieve the vision we have outlined for this exciting new opportunity."
Great times last week :)
Good morning guys!
The FACTS ARE: Undiagnosed Cardiovascular Disease Is a Killer
• 1 in 3 deaths annually are caused by heart disease
and stroke.
• 1.5 million people suffer heart attacks annually in
the U.S.
• Nearly 1/3 of the deaths could be prevented
through proactive changes in lifestyle habits.
• Often the FIRST SYMPTOM of coronary artery
disease is a heart attack.
CHECK the LXGTF Management Team: https://lexingtonbiosciences.com/company/management/
LXGTF Article by Jonathan Maltz, "What is Endothelial Function..." : https://lexingtonbiosciences.com/news/endothelial-function-important-health/
WATCH the amazing LXGTF video: https://vimeo.com/183611304
Morning Italian, good to see you :)
"Breakthrough technology" is a real understatement!!! In LXGTF HeartSentry you have a simple, affordable, portable device that requires no expert training to use and yet by measuring endothelial function it can knock the wind out of the diseases that cause 25% of ALL deaths in the modern world (heart disease and stroke)Its only competition area devices that cost up to six figures, can fill a small room and require medical training to operate.
The license is near! LXGTF engages Diablo research for next step in FDA clearance..
https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html
Beginning of a new week. Go LXGTF!
Good morning everybody!
LXGTF engages Diablo research for next step in FDA clearance..
https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html
this is the reason for the season
The volume is great for the early morning!